CASE REPORT
Pulmonary Mucoraceous Fungal Ball
LK. Lahiri, (Mrs) D. Agarwal, G.E.C.V. Sagar Reddy and Archana Bajoria
Department of Cardiovascular and Thoracic Surgery, Institute of Medical Sciences, Banaras Hindu University,
‘Varanasi (Uttar Pradesh)
ABSTRACT
A case of opportunistic pulmonary infection in the form of fungal ball produced by the family
of mucoraceae in the class of phycomycetes having nonseptate hyphae (cellophane tubules)
with haphazard branching in a post-tubercular immunocompetent patient is described.
Clinical course was chronic with right upper lobe cavity invaded by fungi of mucor species,
pathology was granuloma with blood vessel thrombosis, and a fungus ball. The host had no
associated predisposing diseases. Segmental resectional surgery of the right upper lobe along
with removal of fungus ball under the coverage of modified dose of amphotericin B was per-
formed. Literature scanning revealed rarity of mucormycosis in immunocompetent host.
Key words : Mucorales infection, Lung, Surgery, Amphotericin B.
INTRODUCTION
Phagocyte opportunists infection caused by
the fungi of mucorales order is an occasional
entity, and has six distinct clinical presentations.
In order of frequency, these are thinocerebral,
pulmonary, abdominopelvic, cutaneous,
disseminated and vascular with endocardial
form!, Pulmonary manifestations include from
rapidly progressive fulminant pneumonia, slowly
progressive pulmonary infection, endobronchial
lesion with confinement to a discrete area,
intracavitary fungus ball, and chronic necrotizing,
pulmonary mucormycosis in which fungus
invades, abnormal lung and adjacent pleura®.
Pulmonary mucoraceous fungus ball (PMEB) is
a matted collection of fungal hyphae, cellular
debris, fibrin and mucous, The rarity of such
reports prompted us to describe this case of
chronic colonizing pulmonary mucoraceous
infection along with intracavitary fungal ball in
Undian J Chest Dis Allied Sci 2001; 43 : 107-110]
anon-immunocompromised patient. -
CASE REPORT
‘A48-year-old male presented with cough and
expectoration for four years along with increasing
dyspnoea for six months. The expectorant was
variable, occasionally viscid and foul smelling
and often blood tinged. There was no history of
diabetes, smoking or jaundice. The patient had
received antitubercular drugs for nine months,
12 years prior to this admission. General
examination revealed pallor, grade II clubbing
and generalized lymphadenopathy including
right lower cervical, bilateral axillary and bilateral
inguinal varying from 0.5 cm to 1.5 cm in size,
firm but matted at places. Respiratory system
examination revealed asymmetric, flat right
upper chest along with prominent accessory
muscles of respiration and diminished breath
Correspondence : Dr TK. Lahiri, Professor and Head, Department of Cardiovascular and Thoracic Surgery, Institute
of Medical Sciences, Banaras Hindu University, Varanasi-221 005 (Uttar Pradesh); Tele. : 91-0542-316151 (R), 91-
0542307530 (0); Telefax : 91-0542-316068; E-mail : .108 Pulmonary Mucormycosis
sounds in the right infraclavicular and
suprascapular regions. His biochemical and
hematological examinations were within normal
limits. Sputum was negative for acid-fast bacilli,
and ELISA for HIV was negative. Chest
roentgenogram revealed an opacity in a cavity in
the right upper zone along with retraction of the
right upper intercostal spaces (Figure 1).
Bronchoscopy disclosed distorted right main
bronchus along with crowding and
mucopurulent secretions. The bronchial aspirate
‘was negative for malignant cells and also for acid
fast bacilli. Bronchoalveolar lavage (BAL) and
brush cytology revealed lymphocyte and plasma
cells only. Computed tomography (CT) scan
revealed the presence of an irregular, soft tissue
attentiating mass at the level of right upper lobe
encasing and compressing the right main
bronchi. The CT also disclosed secondary
pulmonic consolidation, and bronchiectatic
changes as evidenced by air bronchogram
(Figure 2). Chronic bronchitis was present in both
lung fields. There was no evidence of
calcification. Contrast enhanced computed
Figure 1. Chest roentgenogram showing fungus ball
in the right upper lobe.
TK Lahiri et al
tomography (CECT) showed heterogeneous
enhancement of the mass. Right posterolateral
thoracotomy revealed marked adhesions,
markedly thickened and vascular parietal pleura
along with complete destruction of the posterior
segment of the right upper lobe due to a post
tubercular cavity. This cavity contained a fungus
ball about 7 cm x 6 cm x 6 cm along with pus.
Removal of the fungus ball along with segmental
resection of right posterior segment and wedge
resection of the apical segment of the right upper
lobe performed. Gross pathological examination
revealed multiple friable, soft masses from 0.2
5m diameter (Figure 3), and also fibrofatty tissue
of 3.5 cm and 2 cm with a greyish white
appearance. Microscopic examination
demonstrated sheets of unseptate hyphae with
haphazard branching and parallel wall. No other
viable cellular elements had been seen.
The section from wedge resected specimen
revealed pseudostratified columner lining with
chronic inflammatory cells comprising plasma
cells and lymphocytes. There was associated
Figure 2. CT scan showing fungus ball on the posterior
segment of the right upper lobe.
Figure 3. Resected large tungus ball.2001; Vol. 43
endothelial cell proliferation. Histologic study of
the fungal mass using hematoxylin-eosin stain
revealed features consistent with pulmonary
mucorales family. Granuloma formed of colonies
of broad nonseptate hyphae with oval
zygophores and sporangiophores (asexual
propagules-Figure 4).
Figure 4. Photomicrograph showing granuloma
formed of colonies of broad nonseptate hyphae with
parallel branching and with oval zygophores and
sporangiophores of mucorales family [H & E x 400]
DISCUSSION
Mucormycosis also known as zygomycosis or
phycomycosis includes infection produced by
fungi of the class of Zygomycetes of the family
Mucoraceae. The species of several allied genera
like Rhizopus, Rhizomucor, Mucor, Absidia,
Conidiobolus, Saksenaca and Cunninghanulla can
produce human infection. The spores of these
organisms are a part of normal respiratory flora.
Predisposing factors of mucorales infection are
associated diabetes, immunosuppressed host,
lymphoma, leukaemia, neutropenia, solid
tumours, elastoplast bandages, burns, renal
disease, long term treatment with steroids and
antimetabolites. Most human infections are
acquired by inhalation of sporangiospores
usually in immunocompromised states. They are
capable of growth under aerobic, anaerobic and
microaerophilic conditions*.
‘The clinical onset may be acute or chronic and
may be life threatening when invasive or indolent
in the immunocompetent hosts. The fungi may
disseminate or result in a pneumonia, fungus
‘The Indian Journal of Chest Diseases & Allied Sciences 109
ball, or may present with and allergic manife-
station.
The main clinical association is with diabetes
or hematological malignancy in mucorales
infection. In minimally immunocompromised
hosts the disease may be asymptomatic, or
produce a slowly progressive upper lobe cavity
colonization with or without a fungal ball. Fungal
balls may be associated with 11 to 17% cases of
tuberculosis, 10% cases of sarcoidosis,
bronchiectasis, chronic lung abscess, radiation
fibrosis, cavitary carcinoma, intralobar
pulmonary sequestration and bronchial
ankylosing spondylitis’. In more severe
immunocompromised host the illness begin as an
acute pneumonia with fever and cough along
with blood vessel invasion, and followed by
pulmonary infarction with haemoptysis and
pleuritic pain with rapidly progressive downhill
course”, The chest roentgenogram may reveal
nodular, lobar, or wedge shaped infiltrate,
mediastinal widening, hilar or mediastinal
adenopathy, bronchopneumonia, solitary nodule,
miliary pattern, cavitation, intracavitary masses
and pleural effusion. A solid rounded mass of
intense density within an ovoid or spherical
cavity, separated from the wall by an air space of
variable size and shape along with or without
movement in different position is classic for
pulmonary fungus ball, roentgenographically’.
‘Computed tomographic scan has been used to
image pulmonary mucormycosis. Involvement
of multiple segments, walls with only thickening
of membranous linings, no air fluid level,
minimal bone destruction, demonstration of
associated infarction, haemorrhage or abscess,
bronchial occlusion, extrapulmonary invasion
and pulmonary artery pseudoaneurysm may be
found’,
Macroscopically pulmonary mucorales with
fungus ball consists of a round to oval shaped
mass of greenish yellow or brown granular
material situated within a cavity composed of
fibrous wall of variable thickness. The diagnosis
of mucorales is based on the presence of broad,
nonseptate (cellophane tubules), upto right
angled branching hyphae stained with
methamine siliver’. Mycologic isolation of the
organism plays a smaller role in diagnosis*. The110 Pulmonary Mucormycosis
organisms are also seen in aqueous potassium
hydroxide preparation. Reliable serologic tests are
not available.
Management lies in timely diagnosis with a
high index of suspicion. The proper therapy of
pulmonary mucoraceous fungus ball is to treat
promptly with amphotericin B and resect the
involved pulmonary tissue*™", Sporadic reports
suggest that cavitary pulmonary lesions are often.
treated beneficially by intracavitary irrigation
with antifungal agents, In clinically stable
patients with acceptable pulmonary reserve,
localized pulmonary disease, and improving
clinical and immune status, strong consideration
should be given for surgical resection of a
pulmonary mass or nodule caused by mucorales
infection". The use of hyperbaric oxygen therapy
as an adjunctive measure has been used. Of
twenty cases of mucormycosis with diabetes
mellitus, nine cases survived segmental resection
or lobectomies", The motality has been improved
from six percent to more than 73 percent. In
patients with widespread bilateral disease in
whom surgical resection is contraindicated
intravascular coil embolism therapy may be
found to terminate hemorrhage, and is life
saving’. Amphotericin B is a naturally occurring,
polyene antibiotic and at a dose of 1.0 to 1.5
mgm/kg/day is effective in pulmonary
mucormycosis". AMBISONE is a smail
unilamellar liposomal preparation in which
amphotericin B is associated noncovalently with
a pure phospholipid bilayer. This can be
administered at 3-5 mgm/kg /day and is superior
to amphotericin B both in terms of efficacy and
safety?" An important azoles group of synthetic
antifungal agents like fluconazole and
itraconazole, and newer azoles like pradimicin
and nikkomycin are only fungistatic, and highly
dependent on the host defence mechanisms for
clearance of the infection. Because of rarity, there
are no case series in the literature of
granulomatous pulmonary zygomycosis without
underlying illness",
REFERENCES
1. Chakrabarti A, Sharma SC, Chander J. Epide-
miology and pathogenesis of paranasal sinus
10.
u
12.
13.
14.
15.
TK. Lahiri et al
mycosis. Otolaryngol Head Neck Surg 1992; 107 :
745-50.
Bigby TD, Serota ML, Tierny LM, Matthay MA.
Clinical spectrum of pulmonary mucormycosis.
Chest 1986; 89 : 435-39.
Hay RJ, Mackenzie DWR. Fungal infections
(Mycoses). In : Weatherall DJ, Ledingham JGG,
Warell DA, ed Oxford Medical Publications : Text
Book of Medicine; 3rd edn. Oxford : Oxford Uni-
versity Press; 1996 : 797-824.
Singh H, Jetley RK . Letters to the Editor :
Mycetoma and aspergilloma. Med J Armed Forces
India 1999; 55 : 376.
Blitzer A, Lawson W. Fungal infections of the
nose and paranasal sinuses. Otolaryngol Clin
North Am 1993; 26 : 1007-35.
Grover FL, Hopeman AR. Mycotic infection.
In: Pearson FG, Deslauriers J, Ginsberg RJ,
Hiebert CA, McKneally ME Urschel HC, ed Tho-
racic Surgery. New York : Churchill Livings- tone;
1995 : 494-96,
Lakhkar BN, Raju KVRKR, Thomas JA. Imaging
diagnosis. J App! Med 1996; 22 : 189-92.
Davies SE. Fungal pneumonia, Med Clin North
Ann 1994; 78 : 1049-63.
McAdams HP, Rosado-de-Christenson M,
Strollo DC, Patz EF. Pulmonary mucormycosis:
Radiologic findings in 32 cases. Am J Roentgenol
1997; 168 : 1541-48.
Brown RB, Johnson JH, Kessinger JM, Sealy WL.
Bronchovascular mucormycosis in the diabetic:
An urgent surgical problem. Ann Thorac Surg
1992; 53 : 854-57.
Myint M. AMBISONE : An overview of current
use. J Appl Med 1999; 25 : 503-07.
Terrell CL, Hughes CE. Antifungal agents used
for deep seated mycotic infections. Mayo Clin
Proc 1992; 67 : 69.
Coukell AJ, Brogden RN. Liposomal
amphotericin B: Therapeutic use in the manage-
‘ment of fungal infections and visceral Leishma~
nniasis. Drugs 1998; 55 : 585-612.
Namder R, Anderson JD, Kline SS. Abelect,
Amphotec, and AmBisome in the neonatal and
pediatric populations : A literature review. J Ped
Pharm Pract 1998; 3 : 13-28.
‘Majid AA, Yi NW. Granulomatous pulmonary
zygomycosis in a patient without underlying
illness. Chest 1991; 100 : 560-61.